TELA logo

TELA TELA Bio, Inc.

NASDAQ · Medical - Devices · Healthcare

$0.82
-0.04 (-4.64%)

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue …

Market Cap: $37.06Mwww.telabio.com

Price

No data yet.

Social Signal Score

43
5d
—
30d
46
3 mentions
—
60d
43
5 mentions
—
90d
41
6 mentions
—
news: 6

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 1Sell 0Strong Sell 0
Avg price target$2+143.9%
Low $2Median $2High $2
Current Consensus

Revenue

$18.96M+943.14%
$1.82M$8.17M$14.52M$20.87M
Mar 2018Sep 2026

Analyst Estimates

FY2025
$-0.82
$-0.85–$-0.79
3 analysts
FY2026
$-0.66
$-0.68–$-0.64
1 analysts
FY2027
$-0.48
$-0.50–$-0.47
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Heather Getz
Sector
Healthcare
Industry
Medical - Devices
Employees
218
Beta
1.36
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-13.22
www.telabio.com